HSBC Holdings
DFTX

HSBC Holdings’s Definium Therapeutics DFTX Stock Holding History

HSBC Holdings’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
+117,482
New +$2.9M ﹤0.01% 1183
2022
Q3 		– Sell
-2,120
Closed -$20K – 3133
2022
Q2 		$20K Sell
2,120
-752
-26% -$9.52K ﹤0.01% 3190
2022
Q1 		$48K Buy
2,872
+323
+13% +$5.6K ﹤0.01% 3202
2021
Q4 		$93K Buy
2,549
+675
+36% +$21.5K ﹤0.01% 3152
2021
Q3 		$93K Buy
+1,874
New +$81K ﹤0.01% 2891

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HSBC Holdings's DFTX Position: Q2 2026 in Review

HSBC Holdings opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 117,482 shares worth $5.53M. The stake represents ﹤0.01% of the portfolio and ranks #1183 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in DFTX as recently as Q2 2022.

HSBC Holdings first reported a position in DFTX in Q3 2021 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • HSBC Holdings held 117,482 shares of Definium Therapeutics worth $5.53M as of Q2 2026.
  • Definium Therapeutics was a new HSBC Holdings position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1183 holding.
  • HSBC Holdings first reported a position in Definium Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.